Clinical research
Clinical Research Map
Clinical trial sites: one pin for each physical site that hosts trials, placed from the address on the trial registration.
- Trial site
- Group of pins (click to zoom)
Showing 1,809 located sites.
Each pin is one trial site, placed on the map from the address on the trial registration, so it shows part of where trials are run, not all of it. A site with no located address has no pin. A site with a public page on Pharma Observatory links to it; other sites show name, place and trial count only.
Looking for contract research suppliers and CROs? Visit Contract Research Map
Trial sites by region
Select a bar to filter by region.
Log scale: bar lengths compare orders of magnitude, not proportions.
| Category | Trial sites |
|---|---|
| Middle East | 1,809 |
Top countries
Country of the site's address. Select a bar to filter.
Log scale: bar lengths compare orders of magnitude, not proportions.
Bar colour shows the country's region, as in the chart by region.
| Category | Trial sites |
|---|---|
| United States | 306,670 |
| Germany | 73,127 |
| France | 73,097 |
| Italy | 48,361 |
| China | 45,791 |
| Japan | 38,701 |
| Spain | 36,382 |
| United Kingdom | 32,384 |
Trial sites
1,809 sites. Sites with a public page link to it on Pharma Observatory.
-
Research Site 36 trials
-
Tbilisi Heart and Vascular Clinic 31 trials
-
LTD Aversi Clinic 28 trials
-
ARENSIA Exploratory Medicine LLC 23 trials
-
LTD New Hospitals 23 trials
-
Tbilisi Heart and Vascular Clinic LTD 22 trials
-
LLC Todua Clinic 20 trials
-
New Hospitals 20 trials
-
Aleksandre Aladashvili Clinic LLC 19 trials
-
Institute of Clinical Oncology 15 trials
-
Pineo Medical Ecosystem 15 trials
-
Research Site 14 trials
-
Investigational Site Number : 2680003 13 trials
-
Multiprofile Clinic Consilium Medulla 13 trials
-
Tbilisi Heart Center 13 trials
-
Aversi Clinic LTD 12 trials
Explore the data behind the map on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.